Medulloblastoma -Case report
Abstract
Medulloblastoma is an infratentorial, mid-line tumour. Incidence of Medulloblastoma is 1.5-
2 cases per 1,00,000 population(1). It presents as 2-3 months of chronic headache, vomiting, ataxia
and visual disturbances. Here is a case of one and half year old child who was developmentally
normal brought with altered sensorium and seizures with no history suggestive of increased
intracranial tension. The blood reports were all normal. The presentation was so acute that acute
metabolic encephalopathy and poisoning were the working diagnosis. CT brain sprang a surprise as
medulloblastoma. This case is presented in view of the rarity of presentation.
Full Text:
PDFReferences
www.medscape.com
nelson textbook 19th edition
robbin textbook of pathology 8th edition
Pediatric Radiation Oncology; Halperin, Constine, Tarbell, Kun
Albright AL, Wisoff JH, Zeltzer PM, et al.: Effects of medulloblastoma resections on outcome in
children: a report from the Children's Cancer Group. Neurosurgery 38 (2): 265-71, 1996.
Packer RJ, Sutton LN, Elterman R, et al.: Outcome for children with medulloblastoma treated with
radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81 (5): 690-8, 1994
Bailey CC, Gnekow A, Wellek S, et al.: Prospective randomised trial of chemotherapy given before
radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and
the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25 (3): 166-78, 1995
Kortmann RD, Kühl J, Timmermann B, et al.: Postoperative neoadjuvant chemotherapy before
radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the
treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT
'91. Int J Radiat Oncol Biol Phys 46 (2): 269-79, 2000.
Taylor RE, Bailey CC, Robinson KJ, et al.: Impact of radiotherapy parameters on outcome in the
International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3
study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 58
(4): 1184-93, 2004.
von Hoff K, Hinkes B, Gerber NU, et al.: Long-term outcome and clinical prognostic factors in
children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J
Cancer 45 (7): 1209-17, 2009.
Rutkowski S, von Hoff K, Emser A, et al.: Survival and prognostic factors of early childhood
medulloblastoma: an international meta-analysis. J Clin Oncol 28 (33): 4961-8, 2010.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University